On Tuesday, Atwood Oceanics, Inc. (NYSE:ATW)’s shares inclined 3.03% to $25.47.
Atwood Oceanics, Inc. (ATW) declared that one of its auxiliaries had reached a contract for a six-month extension of its existing contract with Eni S.p.A. for the jackup rig, the Atwood Beacon. The Atwood Beacon commenced its initial two-year drilling services contract with Eni on December 24, 2013, for operations offshore Italy. The agreement revises the day rate to €117,155, inclusive of equipment upgrade costs, from €135,100 starting March 1, 2015 and extends the Atwood Beacon`s firm commitment from December 24, 2015 through June 2016.
Atwood Oceanics, Inc. is a leading offshore drilling contractor engaged in the drilling and completion of exploratory and developmental wells for the global oil and gas industry. The Company presently owns 12 mobile offshore drilling units and is constructing two ultra-deepwater drillships. The Company was founded in 1968 and is headquartered in Houston, Texas. Atwood Oceanics, Inc. common stock is traded on the New York Stock Exchange under the symbol “ATW.”
Atwood Oceanics, Inc., an offshore drilling contractor, engages in the drilling and completion of exploratory and developmental oil and gas wells worldwide. As of November 10, 2014, it owned a fleet of 13 mobile offshore drilling units, in addition to 3 ultra-deepwater drill ships under construction. The company was founded in 1968 and is headquartered in Houston, Texas.
NRG Energy Inc (NYSE:NRG)’s shares gained 1.49% to $23.10.
NRG Renew LLC, a wholly owned partner of NRG Energy, Inc. (NRG), the country’s largest independent power producer, declared plans to develop a 20 megawatt (MW) solar energy facility that will generate clean, reliable solar power for delivery to Cisco’s San Jose headquarters. NRG Renew LLC will convert its NRG Solar Blythe II location, which is a 153-acre parcel that has been under development by NRG since 2010, into a solar installation that will assist Cisco reach its aim of using renewable sources for at least 25 percent of its electricity needs by 2017. The project is planned to start commercial operation by the end of 2016.
Electricity generated by the solar installation will be sold to Cisco under a 20-year power purchase agreement (PPA), increasing Cisco headquarters’ total use of clean, emission-free electricity.
Located in the Sonoran Desert near the Arizona and California border, the NRG Solar Blythe II location receives plentiful sunshine: For nearly half the year, average temperatures reach 90°F or higher.1 The photovoltaic technology to be installed on-site requires no fuel and minimal water. The amount of emission-free energy generated is predictable to be equivalent to the power needed to serve more than 14,000 homes and to prevent more than 102,000 metric tons of carbon dioxide from entering the atmosphere annually, which is the equivalent of removing more than 21,000 cars from the road. During the construction period, the project is anticipated to create about 200 jobs.
NRG Energy, Inc., together with its auxiliaries, operates as a power company. The company provides electricity; system power, distributed generation, solar and wind products, backup generation, storage and distributed solar, demand response, energy efficiency, and on-site energy solutions; carbon administration and specialty services; and various energy services, such as operations, maintenance, technical, development, and asset administration services.
At the end of Tuesday’s trade, McDonald’s Corporation (NYSE:MCD)‘s shares surged 1.08% to $96.68.
McDonald’s Corporation (MCD) declared the appointments of Robert Gibbs as Executive Vice President, Global Chief Communications Officer and Silvia Lagnado as Executive Vice President, Global Chief Marketing Officer. Both will report to McDonald’s President and CEO Steve Easterbrook.
Gibbs joins McDonald’s from The Incite Agency, a planned communications advisory firm he co-founded in 2013. Prior to that he held several senior advisory roles in the White House, serving as President Barack Obama’s press secretary during his first term, then as senior campaign advisor during his re-election campaign. He will replace Bridget Coffing who declared her retirement earlier this year after 30 years with the company.
McDonald’s Corporation operates and franchises McDonald’s restaurants in the United States, Europe, the Asia/Pacific, the Middle East, Africa, Canada, and Latin America. The company’s restaurants offer various food products, soft drinks, coffee, and other beverages.
Opko Health Inc. (NYSE:OPK), ended its Tuesday’s trading session with -0.03% loss, and closed at $16.82.
Opko Health Inc. (OPK) may fit the first condition of being at or near its highs, but it does not fulfill the second. Those short Opko don’t seem to mind all that much, being that 44.92M shares are presently held short, constituting 67% of the float. That’s about a million more shares than last month, representing over $15M in capital spent on shorting the stock in one month, at least.
While shorting itself may tend to discourage some retail investors from taking a position, institutional investors in addition to company insiders are usually astute enough to know that for every short seller, there is a buyer of those shares on the other side. Close to 70% of Opko’s float is held by either insiders or institutions, and it is doubtful that any of those shares will be put on the open market any time soon. And even if some are, the company’s founder and CEO, Dr. Phillip Frost, is picking shares at the same pace that shortsellers are borrowing them to sell.
OPKO Health, Inc., a biopharmaceutical and diagnostics company, engages in the discovery, development, and commercialization of novel and proprietary technologies in the United States and internationally. It operates through two segments, Pharmaceuticals and Diagnostics. The company develops various solutions to diagnose, treat, and prevent various conditions, counting point-of-care tests, molecular diagnostics tests, laboratory developed tests, and proprietary pharmaceuticals and vaccines. Its products comprise 4Kscore test that measures the blood plasma levels of four different prostate-derived kallikrein proteins.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
